Auto-generated challenge from hypothesis h-var-95b0f9a6bc (score=0.821). Target: MAPT. Question: Can targeting Glymphatic-Mediated Tau Clearance Dysfunction lead to therapeutic benefit in neurodegeneration? Falsifiable prediction: Enhanced glymphatic clearance will reduce tau propagation and improve cognitive outcomes.